C G Regårdh - Concepedia

Author

C G Regårdh

Also Known As

C G Regårdh, C. -G. Regårdh, C. G. RegÅrdh, C. G. Regårdh, C.-G. Regårdh, C.-G. RegÅrdh, C.G. Regårdh, C.‐G. REGARDH, C.‐G. Regårdh, Carl G. Regardh

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (Sweden)Sahlgrenska University Hospital Martin Luther University Halle-Wittenberg University of Gothenburg

About

C G Regårdh is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	1.5K
2	Biochemistry	5	5	228
3	Natural Sciences	1	1	459
4	Public Health	1	1	39
5	Anesthesia	1	1	30

C G Regårdh

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Caco‐2 versus Caco‐2/HT29‐MTX Co‐cultured Cell Lines: Permeabilities Via Diffusion, Inside‐ and Outside‐Directed Carrier‐Mediated Transport Constanze Hilgendorf, Hildegard Spahn‐Langguth, C G Regårdh, Journal of Pharmaceutical Sciences Signal TransductionCell CommunicationPermeabilities Via DiffusionNatural SciencesMembrane Transport	2000	459
Pharmacokinetic studies on the selectiveβ 1-receptor antagonist metoprolol in man C G Regårdh, K. O. Borg, Rustan Johansson, Journal of Pharmacokinetics and Biopharmaceutics Pharmacokinetic StudiesPharmacological StudyPharmacologyPharmacological AgentClinical Pharmacology	1974	189
Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. A Miniscalco, Jonas Lundahl, C G Regårdh, Journal of Pharmacology and Experimental Therapeutics	1992	180
Effects of grapefruit juice ingestion - pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men Jonas Lundahl, C G Regårdh, B. Edgar, European Journal of Clinical Pharmacology PharmacologyGrapefruit Juice IngestionHealthy Men	1997	164
Role of P‐glycoprotein‐mediated secretion in absorptive drug permeabiity: An approach using passive membrane permeability and affinity to P‐glycoprotein††Dedicated to Prof. B. C. Lippold on the occasion of his 60th birthday. Stephan Döppenschmitt, Hildegard Spahn‐Langguth, C G Regårdh, Journal of Pharmaceutical Sciences	1999	125
Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long‐term treatment Calle Bengtsson, G. Johnsson, C G Regårdh Clinical Pharmacology & Therapeutics	1975	113
Felodipine kinetics in healthy men Boo Edgar, C G Regårdh, G. Johnsson, Clinical Pharmacology & Therapeutics	1985	111
Interethnic Differences in Omeprazole Metabolism in the Two S-Mephenytoin Hydroxylation Phenotypes Studied in Caucasians and Orientals Takashi Ishizaki, Dong‐Ryul Sohn, Kaoru Kobayashi, Therapeutic Drug Monitoring PharmacotherapyTranslational PharmacologyChinese EmsPharmacological StudyToxicology	1994	103
Pharmacokinetic and Pharmacodynamic Properties of Metoprolol in Patients with Impaired Renal Function L. Jordö, P.-O. Attman, Mattias Aurell, Clinical Pharmacokinetics Pharmacodynamic PropertiesRenal FunctionPharmacological StudyMedicineChronic Kidney Disease	1980	84
Characterization of Binding Properties to Human P-Glycoprotein: Development of a [3H]Verapamil Radioligand-Binding Assay Stephan Döppenschmitt, Peter Langguth, C G Regårdh, Journal of Pharmacology and Experimental Therapeutics	1999	75

Page 1